Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

Journal of Virology

Volumn 75, Issue 23, 2001, Pages 11630-11640

  Chen, D ^a   Weis, K F ^a   Chu, Q ^a   Erickson, C ^a   Endres, R ^a   Lively, C R ^a   Osorio, J ^a   Payne, L G ^a  

^a PowderJect Vaccines Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GOLD; HEPATITIS B SURFACE ANTIGEN; SYNTHETIC PEPTIDE; VACCINE; VIRUS ANTIGEN; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; EPIDERMIS; FEMALE; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOFLUORESCENCE MICROSCOPY; INFLUENZA VIRUS; LANGERHANS CELL; LYMPHOCYTE DEPLETION; MOUSE; NEEDLE; NONHUMAN; POWDER; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INACTIVATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; POWDERS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0035158888     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.23.11630-11640.2001     Document Type: Article

References (56)

1. Immunological memory and protective immunity: Understanding their relation
2. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
3. Immature dendritic cells phagocytose apoptotic cells via αVβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
4. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
5. HIV-peplotion vaccine. A novel approach to vaccination against AIDS by transepithelial transport of viral peptides to Langerhans cells for induction of cytolytic T cells by HLA class I and CD1 molecules for long term protection
6. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
7. + T cell help
8. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties
9. The CTL's kiss of death
10. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
11. Distribution of ATPase-positive Langerhans cells in normal adult skin
12. DNA-based immunization by in vivo transfection of dendritic cells
13. Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus
14. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
15. Priming of cytotoxic T lymphocytes by DNA vaccines: Requirements for professional antigen presenting cells and evidence for antigen transfer from myocytes
16. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization
17. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations
18. Antiviral vaccines
19. DNA vaccines: Immunology, application, and optimization
20. DNA vaccines: A key for inducing long-term cellular immunity
21. + T cells to intracellular bacteria
22. + T cell effector mechanisms in resistance to infection
23. Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization
24. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses
25. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
26. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses
27. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
28. QS-21 and QS-7: Purified saponin adjuvants
29. Contribution of cells at the sites of DNA vaccination to the generation of antigen-specific immunity and memory
30. Sex differences in the densities of epidermal Langerhans cells of the mouse
31. + memory T cells
32. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus
33. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo
34. Functional aspects of ISCOMS
35. Antigen presentation in the immune response to infectious diseases
36. Mechanisms of MHC class I-restricted antigen processing
37. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery
38. MHC class II-restricted antigen processing and presentation
39. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation
40. + T-helper and a T-killer cell
41. Hypothesis: How licensed vaccines confer protective immunity
42. Perspective: Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum
43. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules
44. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
45. - T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
46. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens
47. T-cell help for eytotoxic T lymphocytes is mediated by CD40-CD40L interactions
48. Antigenic conservation of H1N1 swine influenza viruses
49. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
50. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
51. Cytotoxic T cell responses to intracellular pathogens
52. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system
53. Quantitative analysis of the immunopotency of genetically transfected dentritic cells
54. Generation of MHC class I restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
55. Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant
56. CD40-ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection